Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check44 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated to version v2.14.0, adding a new type of intervention and contact number, while removing multiple principal investigators and the previous version v2.13.3.SummaryDifference8%
- Check95 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.